Non-Cochrane · intervention · PM42927204

Short Implants Versus Sinus Floor Elevation With Standard Implants in the Atrophic Posterior Maxilla: A Systematic Review and Meta-Analysis.

Abdallaoui Maane Salma, Muelas Sanchez Cesar, Lanciego Manuel, et al. · Cureus · 2026 · PubMed · doi:10.7759/cureus.116807

Findings

11 findings

Population
Adults with atrophic posterior maxillaShort implants ≤6 mm without sinus floor elevationStandard implants >8 mm with sinus floor elevationBiological complicationsno estimate extracted
Low
Studies not reported
Adults with posterior maxillary atrophy (subantral bone height <10 mm)Short implants (<=6 mm) placed without sinus floor elevationStandard implants (>8 mm) placed with sinus floor elevation (lateral or transcrestal)Implant survival (patient level)
Latest follow-up per cohort (36 to 120 months) · Sensitivity analysis: event-free cohort reintroduced with 0.5 continuity correction, Hartung-Knapp adjustment
RR 0.99 [0.87, 1.12]
GRADE not reported
3 studies · 174 participants
Adults with posterior maxillary atrophy (subantral bone height <10 mm)Short implants (<=6 mm) placed without sinus floor elevationStandard implants (>8 mm) placed with sinus floor elevation (lateral or transcrestal)Implant survival (patient level)
Latest follow-up per cohort (36 to 120 months) · Sensitivity analysis: Paule-Mandel between-study variance estimator
RR 1.00 [0.56, 1.76]
GRADE not reported
2 studies · 154 participants
Adults with atrophic posterior maxillaShort implants ≤6 mm without sinus floor elevationStandard implants >8 mm with sinus floor elevationProsthetic and technical complicationsno estimate extracted
Very low
Studies not reported
Adults with posterior maxillary atrophy (subantral bone height <10 mm)Short implants (<=6 mm) placed without sinus floor elevationStandard implants (>8 mm) placed with sinus floor elevation (lateral or transcrestal)Implant failure (patient level)
Latest follow-up per cohort (36 to 120 months) · Failure scale: Peto odds ratio
Peto OR 1.70 [0.17, 16.86]
GRADE not reported
3 studies · 174 participants
Adults with atrophic posterior maxillaShort implants ≤6 mm without sinus floor elevationStandard implants >8 mm with sinus floor elevationMarginal bone loss
12 to 120 months
no estimate extracted
Very low
3 studies
Adults with posterior maxillary atrophy (subantral bone height <10 mm)Short implants (<=6 mm) placed without sinus floor elevationStandard implants (>8 mm) placed with sinus floor elevation (lateral or transcrestal)Implant survival (patient level)
Latest follow-up per cohort (36 to 120 months) · Sensitivity analysis: fixed-effect Mantel-Haenszel model
RR 0.99 [0.94, 1.04]
GRADE not reported
2 studies
Adults with posterior maxillary atrophy (subantral bone height <10 mm)Short implants (<=6 mm) placed without sinus floor elevationStandard implants (>8 mm) placed with sinus floor elevation (lateral or transcrestal)Implant survival (patient level)
Latest follow-up per cohort (36 to 120 months) · Primary analysis: random effects, DerSimonian-Laird with Hartung-Knapp adjustment
RR 1.00 [0.56, 1.76]
Very low
Downgraded: risk of bias, imprecision, inconsistency
2 studies · 154 participants
Adults with posterior maxillary atrophy (subantral bone height <10 mm)Short implants (<=6 mm) placed without sinus floor elevationStandard implants (>8 mm) placed with sinus floor elevation (lateral or transcrestal)Implant survival (patient level)
Latest follow-up per cohort (36 to 120 months) · Sensitivity analysis: event-free cohort reintroduced with 0.5 continuity correction, unadjusted DerSimonian-Laird
RR 0.99 [0.93, 1.05]
GRADE not reported
3 studies · 174 participants
Adults with posterior maxillary atrophy (subantral bone height <10 mm)Short implants (<=6 mm) placed without sinus floor elevationStandard implants (>8 mm) placed with sinus floor elevation (lateral or transcrestal)Implant survival (implant level)
Latest follow-up per cohort (36 to 120 months) · Sensitivity analysis: implant-level unit of analysis
RR 1.00 [0.93, 1.08]
GRADE not reported
2 studies
Adults with posterior maxillary atrophy (subantral bone height <10 mm)Short implants (<=6 mm) placed without sinus floor elevationStandard implants (>8 mm) placed with sinus floor elevation (lateral or transcrestal)Implant survival (patient level)
Latest follow-up per cohort (36 to 120 months) · Sensitivity analysis: unadjusted DerSimonian-Laird interval
RR 1.00 [0.91, 1.09]
GRADE not reported
2 studies · 154 participants

Included primary studies 4

Open in Studies
StudyYearAlso included byOutcomes it informs hereTrial data
Thoma 2024
Randomized controlled multi-centre study comparing shorter dental implants (6 mm) to longer dental implants (11-15 mm) in combination with…
PMID:38296249
20241 other reviewImplant survival (patient level)not extracted yet
Bechara 2017
Short (6-mm) dental implants versus sinus floor elevation and placement of longer (≥10-mm) dental implants: a randomized controlled trial…
PMID:27402427
2017this review onlyImplant survival (patient level)not extracted yet
Felice 2015
Short implants as an alternative to crestal sinus lift: A 1-year multicentre randomised controlled trial.
PMID:26669547
2015this review onlyImplant survival (patient level)not extracted yet
Pohl 2017
Short dental implants (6 mm) versus long dental implants (11-15 mm) in combination with sinus floor elevation procedures: 3-year results…
PMID:28081288
2017this review onlynot statednot extracted yet

Overlap with other reviews

Reviews that include the same primary studies are not independent evidence. Shared counts match studies by PMID, DOI or NCT, and otherwise by author and year (a probable match). Only the non-Cochrane dental reviews have study lists, so overlap with Cochrane reviews is not counted yet.

Review question

ElementPlanned (methods)Found (results)
PopulationAdults aged >=18 years with posterior maxillary atrophy (subantral bone height <10 mm)Patients with atrophic posterior maxilla, residual subantral bone height 5 to 7 mm (n=174 randomized patients, 3 cohorts)
InterventionShort implants (<=6 mm) placed without sinus floor elevationShort implants 5 to 6 mm without sinus floor elevation (n=93)
ComparisonStandard implants (>8 mm) placed with sinus floor elevation (lateral or transcrestal approach)Standard implants 10 to 15 mm with sinus floor elevation (n=81)
OutcomesImplant survival (primary); marginal bone loss; biological and prosthetic complicationsImplant survival (pooled, 2 cohorts, n=154; Peto OR on failure scale, 3 cohorts); marginal bone loss and complications narrative only
Study designsRandomized controlled trials published 2014-2025RCTs (n=3 cohorts, 4 publications)
TimingMinimum follow-up 12 months12 months (1 cohort), 36 months (1 cohort), 120 months (1 cohort)

AMSTAR 2 items

Two independent extractors rated each item. Their ratings are shown side by side because they have not been reconciled yet. The overall rating follows Shea et al. 2017: one critical flaw gives Low, more than one gives Critically Low.

ItemExtractor AExtractor BAgree
1Research question includes PICO componentsYesYesyes
2Protocol established before the reviewcriticalPartial YesPartial Yesyes
3Choice of study designs explainedYesNono
4Comprehensive literature searchcriticalPartial YesPartial Yesyes
5Study selection in duplicateYesYesyes
6Data extraction in duplicateYesYesyes
7List of excluded studies with reasonscriticalNoNoyes
8Included studies described in detailPartial YesYesno
9Risk of bias assessed satisfactorilycriticalRCT: Yes · NRSI: N/ARCT: Yes · NRSI: N/Ayes
10Funding of included studies reportedNoNoyes
11Appropriate meta-analysis methodscriticalRCT: Yes · NRSI: N/ARCT: Yes · NRSI: N/Ayes
12Impact of risk of bias on the pooled resultsNoYesno
13Risk of bias accounted for in interpretationcriticalYesYesyes
14Heterogeneity explainedYesYesyes
15Publication bias investigatedcriticalNoNoyes
16Conflicts of interest reportedYesYesyes
OverallCritically LowCritically Lowyes